Hydromer, Inc.

HYDI

US4490011065

Specialty Chemicals

Market Closed - Nyse Other stock markets 15:54:25 14/05/2024 BST			5-day change	1st Jan Change
0.35 ^USD	-35.19%		0.00%	+89.19%

01-16	Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023	CI
01-16	Hydromer, Inc. Revises Fiscal Year from June 30 to December 31	CI

N8 Medical, LLC Partners with Hydromer Inc. and Biosearch Medical Products, Inc for Material Supply and Production of the CeraShield

April 23, 2020 at 07:47 pm

N8 Medical, LLC has partnered with Hydromer Inc. and its wholly owned subsidiary and med-tech division, Biosearch Medical Products, Inc., in connection with material supply and production of the CeraShield™ Endotracheal Tubes for this important effort.

Latest news about Hydromer, Inc.

Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023	01-16	CI
Hydromer, Inc. Revises Fiscal Year from June 30 to December 31	01-16	CI
Hydromer, Inc. Announces the Relaunch of its Legendary SeaSlide?? Hydrophilic Watercraft Coating	01-16	CI
Hydromer, Inc. Announces Board Changes	08/08/23	CI
Hydromer, Inc Appoints Michael E. Torti as Chief Executive Officer	25/04/23	CI
Hydromer, Inc. Removes Peter Von Dyck as CEO	06/04/23	CI
Hydromer, Inc. Appoints Cam Cruickshank as Board of Directors	11/01/23	CI
Hydromer, Inc. Appoints Cortney Wells as Director of Finance	09/11/22	CI
Hydromer, Inc. Announces That New Facility in North Carolina Is Fully Operational with Extensive New Capabilities	23/09/21	CI
Hydromer Inc. Announces the Addition of A New Global Business Development Manager to Propel Growth	29/06/21	CI
Hydromer Selected as Key Coatings Provider for Avinger’s Image-Guided PAD Therapeutic Devices	20/05/21	CI
Hydromer Inc Signs Agreement to Sell Their Hand and Surface Sanitizer Lines, Hydromer First Responder, HydroProtect and EscenciaProtect on the Stockd e-Commerce Marketplace	03/12/20	CI
Hydromer as the Exclusive Coatings Partner for N8 Announces the CeraShield Coating Has Demonstrated the Ability to Inhibit and Reduce the Growth of Covid-19 Virus on Tube Surfaces	18/08/20	CI
Hydromer Accelerates Its First Responder Sanitizer Production to Meet Growing Demand	30/04/20	CI
Hydromer, Inc. and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients	24/04/20	CI
N8 Medical, LLC Partners with Hydromer Inc. and Biosearch Medical Products, Inc for Material Supply and Production of the CeraShield	23/04/20	CI
Hydromer Enters into New Commercial Relationship Agreements with Multiple Clients to Kick-Off the New Year 2020	14/01/20	CI
Hydromer Inc. Announces its Partnership With EuroDev to Expand on Demand for its Specialty Coatings Products in Europe	06/11/19	CI
Hydromer Inc. Announces the Launch of Its Next Generation Website to Provide Clients with A Better User Experience	12/07/19	CI
Hydromer, Inc. Announces Board Appointments	04/06/19	CI
Hydromer Inc. Announces Advancement of Manufacturing Capabilities with Relocation to North Carolina	24/04/19	CI
Hydromer, Inc. Announces Management Changes	29/01/19	CI
Hydromer, Inc. Announces Dividend, Payable on October 8, 2018	19/09/18	CI
Hydromer, Inc Announces Executive Changes	13/09/18	CI
Huvepharma AD acquired T-HEXX animal healthcare business of Hydromer, Inc. for $6.5 million.	27/08/18	CI

Chart Hydromer, Inc.

Duration

Period

More charts

Company Profile

Hydromer, Inc. is a provider of hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices. The Company is engaged in providing business-to- business (B2B) surface modification and coating solutions provider. The Company offers polymer research and development, and manufacturing services capabilities for a variety of applications. Its customers are located across North and South America, Europe, the Middle East, and Asia-Pacific. Its segments include Medical and Industrial. Medical segment provides medical coatings support to specialized FDA approved medical devices and medical coatings that reduce insertion and withdrawal friction and potential trauma and enhance the performance of medical devices used in anatomies of the human body. The Industrial segment provides customized anti-fog, anti-frost, and condensation-control coating solutions for a variety of applications on many substrates including polycarbonate, glass, metal, and polyurethane.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
HYDROMER, INC.	+89.19%	1.93M
ECOLAB INC.	+17.53%	66.74B
SIKA AG	+3.73%	49.42B
GIVAUDAN SA	+21.67%	42.17B
FUJIFILM HOLDINGS CORPORATION	+21.48%	26.37B
EMS-CHEMIE HOLDING AG	+10.57%	19.17B
CELANESE CORPORATION	-2.43%	16.73B
SYMRISE AG	+5.88%	15.99B
ALBEMARLE CORPORATION	-14.90%	14.86B
POSCO FUTURE M CO., LTD.	-27.16%	14.85B

Other Specialty Chemicals

Hydromer, Inc.

Equities

HYDI

US4490011065

Specialty Chemicals

N8 Medical, LLC Partners with Hydromer Inc. and Biosearch Medical Products, Inc for Material Supply and Production of the CeraShield

Latest news about Hydromer, Inc.

Chart Hydromer, Inc.

Company Profile

Sector Other Specialty Chemicals